Safety and health-related quality of life following maternal respiratory syncytial virus (RSV) and diphtheria–tetanus–acellular pertussis (DTaP) vaccinations
Maternal respiratory syncytial virus (RSV) and pertussis vaccinations are recommended in some countries. While Tdap is widely used in pregnant women, DTaP is the approved pertussis vaccine in Japan. This study aimed to evaluate the safety of maternal RSV and DTaP vaccination, including reactogenicit...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis Group
2026-12-01
|
| Saila: | Human Vaccines & Immunotherapeutics |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.tandfonline.com/doi/10.1080/21645515.2026.2637294 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
